tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

APGE Stock Latest News

Buy Rating for Apogee Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook
RatingsBuy Rating for Apogee Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook
18d ago
APGE
Apogee Therapeutics Reports Q3 2025 Financial Progress
PremiumCompany Announcements
Apogee Therapeutics Reports Q3 2025 Financial Progress
20d ago
APGE
Positive Buy Rating for Apogee Therapeutics Driven by Promising Clinical Trials and Strategic Advancements
PremiumRatings
Positive Buy Rating for Apogee Therapeutics Driven by Promising Clinical Trials and Strategic Advancements
21d ago
APGE
Apogee Therapeutics Announces Positive Phase 1 Results
PremiumCompany Announcements
Apogee Therapeutics Announces Positive Phase 1 Results
21d ago
8K
APGE
Apogee Therapeutics reports Q3 net loss $65M vs. $49M last year
PremiumThe Fly
Apogee Therapeutics reports Q3 net loss $65M vs. $49M last year
21d ago
APGE
Apogee Therapeutics sees cash runway into 2H28
PremiumThe FlyApogee Therapeutics sees cash runway into 2H28
21d ago
APGE
Apogee Therapeutics announces interim Phase 1 results for APG333
Premium
The Fly
Apogee Therapeutics announces interim Phase 1 results for APG333
21d ago
APGE
Apogee Therapeutics price target raised to $70 from $60 at RBC Capital
Premium
The Fly
Apogee Therapeutics price target raised to $70 from $60 at RBC Capital
28d ago
APGE
Craig-Hallum bullish on Apogee Therapeutics, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on Apogee Therapeutics, initiates with a Buy
28d ago
APGE
Apogee Therapeutics initiated with a Buy at Craig-Hallum
PremiumThe Fly
Apogee Therapeutics initiated with a Buy at Craig-Hallum
28d ago
APGE
Apogee Therapeutics’ APG777 Study: A Potential Breakthrough in Atopic Dermatitis Treatment
PremiumCompany Announcements
Apogee Therapeutics’ APG777 Study: A Potential Breakthrough in Atopic Dermatitis Treatment
1M ago
APGE
Apogee Therapeutics’ New Study on Atopic Dermatitis: What Investors Need to Know
PremiumCompany Announcements
Apogee Therapeutics’ New Study on Atopic Dermatitis: What Investors Need to Know
1M ago
APGE
Apogee Therapeutics’ Promising Update on Long-term APG777 Study for Atopic Dermatitis
PremiumCompany AnnouncementsApogee Therapeutics’ Promising Update on Long-term APG777 Study for Atopic Dermatitis
1M ago
APGE
Mizuho Securities Recommends Buy for Apogee Therapeutics Due to Promising APG777 Efficacy in Th2 Inflammatory Diseases
Premium
Ratings
Mizuho Securities Recommends Buy for Apogee Therapeutics Due to Promising APG777 Efficacy in Th2 Inflammatory Diseases
1M ago
APGE
Apogee Therapeutics initiated with an Outperform at Mizuho
Premium
The Fly
Apogee Therapeutics initiated with an Outperform at Mizuho
1M ago
APGE
Short Report: Fluence Energy short interest at record high
PremiumThe Fly
Short Report: Fluence Energy short interest at record high
1M ago
NNE
APGE
3 Best Stocks to Buy Now, 10/17/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 10/17/2025, According to Top Analysts
2M ago
FI
APGE
Apogee Therapeutics Raises $323.3 Million in Offering
PremiumCompany Announcements
Apogee Therapeutics Raises $323.3 Million in Offering
2M ago
8K
APGE
Buy Recommendation for Apogee Therapeutics: Promising Clinical Developments and Strategic Financial Moves
PremiumRatings
Buy Recommendation for Apogee Therapeutics: Promising Clinical Developments and Strategic Financial Moves
2M ago
APGE
Apogee Therapeutics price target lowered to $82 from $87 at BofA
PremiumThe FlyApogee Therapeutics price target lowered to $82 from $87 at BofA
2M ago
APGE
Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00
Premium
The Fly
Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00
2M ago
APGE
Closing Bell Movers: Costco nudges higher after September sales
Premium
The Fly
Closing Bell Movers: Costco nudges higher after September sales
2M ago
AZZ
RGP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >